SCHEMBL21029641

SCHEMBL21029641

CSN[C@H](CCCC(=O)C(C)C)C(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21029776 0.89 — —
SCHEMBL21029881 0.83 — —
SCHEMBL18513359 0.81 NOD1 (0.34) —
SCHEMBL22844806 0.79 CTSK (0.32) —
SCHEMBL19543400 0.79 CTSK (0.32) —
SCHEMBL24786139 0.76 LTA4H (0.32) —
SCHEMBL21262052 0.76 C3AR1 (0.34) —
SCHEMBL21216105 0.74 ACE (0.38) —
SCHEMBL20372778 0.71 LTA4H (0.42) —
SCHEMBL24468878 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190160176-A1 TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS ARBUTUS BIOPHARMA CORPORATION (CA) 2019-05-30 — — US disclosed
Send feedback